Literature DB >> 17178699

The diagnosis and differential diagnosis of endogenous Cushing's syndrome.

Polyzois Makras1, Georgios Toloumis, Dimitrios Papadogias, Gregory A Kaltsas, Michael Besser.   

Abstract

Cushing's syndrome (CS) is a physically and psychologically disabling disease associated with high morbidity resulting from inappropriate elevation of circulating free cortisol levels. The main features of CS are disturbance of the normal circadian rhythm of cortisol secretion, impairment of the normal feedback of the hypothalamo-pituitary-adrenal (HPA)-axis, and excessive integrated 24 hours cortisol secretion. All biochemical tests used for the diagnosis of CS rely upon the ascertainment of a disturbance of these features. However, the diagnosis of CS (endogenous hypercortisolism) still remains a challenge, although the evolution of several diagnostic tests has allowed diagnosis at an earlier stage. In the initial investigation of CS, tests of high sensitivity are required to identify patients at risk, which are followed by tests of high specificity to confirm the diagnosis and establish the precise aetiology. This review will discuss the various causes of endogenous CS and focus on established and evolving diagnostic procedures used for its diagnosis, as several studies with large number of patients have recently appeared in the literature validating current practice and proposing improved diagnostic algorithms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178699     DOI: 10.14310/horm.2002.11189

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  6 in total

Review 1.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  CT and 111In-pentetreotide SPECT of hilar ACTH-producing neuroendocrine tumor associated with Cushing's syndrome and massive bilateral adrenal gland hyperplasia.

Authors:  Wichana Chamroonrat; Drew A Torigian; Warren B Gefter; Leslie A Litzky; Chaitanya Divgi
Journal:  J Radiol Case Rep       Date:  2009-08-01

Review 3.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

4.  Kidney Stones as an Underrecognized Clinical Sign in Pediatric Cushing Disease.

Authors:  Sara H Rahman; Georgios Z Papadakis; Margaret F Keil; Fabio R Faucz; Maya B Lodish; Constantine A Stratakis
Journal:  J Pediatr       Date:  2015-12-15       Impact factor: 4.406

5.  Cushing Syndrome Secondary to Primary Neuroendocrine Lung Carcinoma.

Authors:  A Zainal; O Akinsola; K Rajamani
Journal:  Case Rep Endocrinol       Date:  2019-07-24

6.  11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease.

Authors:  Hanna F Nowotny; Leah Braun; Frederick Vogel; Martin Bidlingmaier; Martin Reincke; Lea Tschaidse; Matthias K Auer; Christian Lottspeich; Stefan A Wudy; Michaela F Hartmann; James Hawley; Joanne E Adaway; Brian Keevil; Katharina Schilbach; Nicole Reisch
Journal:  Eur J Endocrinol       Date:  2022-09-29       Impact factor: 6.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.